Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-19,923
Closed -$1.25M 495
2025
Q1
$1.25M Sell
19,923
-129,939
-87% -$8.03M 0.03% 346
2024
Q4
$8.54M Buy
149,862
+105,257
+236% +$6.22M 0.22% 133
2024
Q3
$2.62M Buy
44,605
+25,392
+132% +$1.39M 0.07% 212
2024
Q2
$1.04M Buy
+19,213
New +$1.06M 0.03% 299
2023
Q3
Sell
-11,487
Closed -$658K 384
2023
Q2
$658K Buy
+11,487
New +$670K 0.02% 274
2023
Q1
Sell
-138,746
Closed -$8.16M 373
2022
Q4
$8.16M Buy
+138,746
New +$8.78M 0.4% 74

Other funds holding CTVA

J. Goldman & Co's CTVA Position: Q2 2025 in Review

J. Goldman & Co sold out of Corteva (CTVA) in Q2 2025, closing a stake of 19,923 shares — an estimated $1.25M sold.

J. Goldman & Co first reported a position in CTVA in Q4 2022 and held it in 6 quarters. The position peaked at $8.54M in Q4 2024. 1,400 funds tracked by Wall St. Rank hold CTVA as of Q2 2025.

  • J. Goldman & Co reported no remaining Corteva position as of Q2 2025 after selling out during the quarter.
  • J. Goldman & Co sold 19,923 Corteva shares in Q2 2025, an estimated $1.25M.
  • J. Goldman & Co first reported a position in Corteva in Q4 2022 and held it in 6 quarters.
  • J. Goldman & Co's Corteva position peaked at $8.54M in Q4 2024.
  • 1,400 funds tracked by Wall St. Rank held Corteva as of Q2 2025.

Based on J. Goldman & Co's 13F filing for Q2 2025, filed 14 Aug 2025.